Background Background A 2019 review discussing the role of gastric pentadecapeptide body protection compound BPC 157 in accelerating musculoskeletal soft tissue healing notes that BPC 157 has shown significant promise in healing of various tissues including tendons, ligaments, skeletal muscles, and bones
Some protocols use GLOW for maintenance and switch to KLOW when healing from injury or managing a flare of inflammatory symptoms
Less necrosis developed in treated wounds, suggesting the peptide helped preserve marginally viable tissue that might otherwise have died
however, the product was discontinued by Genentech/Alkermes in 2004 for financial reasons (Nutropin Depot required significantly more resources to produce than the rest of the Nutropin line [88] )
However, preclinical studies demonstrate therapeutic effects with once-daily or even less frequent administration, suggesting tissue distribution, receptor binding, or cellular signaling effects extend beyond plasma clearance
Supplied in a consistent capsule format, SLUBAM enables repeatable experimental conditions and reliable data collection